News Release

ISMP Issues Revised and Expanded Guidelines for the Safe Use of Smart Infusion Pumps

Despite the ability of smart infusion pumps to detect and warn about possible medication errors, healthcare organizations often are not utilizing this important technology to its full potential and serious errors have persisted. The Institute for Safe Medication Practices (ISMP) has published updated guidelines to help healthcare practitioners maximize the intended safety benefits of smart infusion pumps and better position their organizations for bi-directional interoperability with the electronic health record.

“Infusion pump-related errors have frequently occurred due to a failure to engage the dose error-reduction system and the ease with which providers may select the wrong drug library entry or override serious alerts,” says ISMP Director of Consulting Services Michelle Mandrack, MSN, RN. “ISMP has sought input from end users and key stakeholders to identify safety gaps and expand the compendium of expert-and evidence-based best practices available in this area to better protect patients.”

Even when organizations optimize the use of smart infusion pump technology, problems can still exist, often stemming from pumps operating in isolation of other electronic systems and requiring manual programming and documentation by the end user. The ISMP Guidelines for Optimizing Safe Implementation and Use of Smart Infusion Pumps outline specific error-reduction strategies to address:

  • Infrastructure

  • Drug Libraries

  • Continuous Quality Improvement (CQI) Data

  • Clinical Workflow

  • Interoperability with the EHR

ISMP published its original smart infusion pump guidelines in 2009. In 2018, ISMP held a second smart infusion pump summit to discuss issues raised by errors reported to the ISMP National Medication Errors Reporting Program (ISMP MERP) and published in the literature since the original guidelines were issued. The second summit was funded by an educational grant from Baxter, B. Braun, BD, ICU Medical, and Ivenix. Participants included organizational end users, smart infusion pump vendors, and representatives of professional and regulatory organizations, who focused on gaining consensus on safe practices that were incorporated into the updated guidelines.

ISMP also has conducted three practitioner surveys to better assess successes, safety concerns, and barriers to the optimization of smart infusion pumps. Identified barriers include significant limitations of pump capabilities, alarm fatigue, persistent deficiencies related to library use and updates, availability of pumps, programming workflow, associated risks with secondary infusions, and pump data analysis.

For a copy of the ISMP Guidelines for Optimizing Safe Implementation and Use of Smart Infusion Pumps, click here. Please note that sign-in and/or creation of a free user account may be required for access.

More News

During the COVID-19 pandemic, the Institute for Safe Medication Practices (ISMP) is moving to a special editions of the ISMP Medication Safety Alert! acute care newsletter that will focus only on information healthcare practitioners may find useful in their response efforts. As the world grapples